GUSELKUMAB INDUCTION RESTORES INTESTINAL IMMUNE HOMEOSTASIS AND PROMOTES EPITHELIAL REPAIR IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Publié en janvier 2024 GASTROENTEROLOGY

HIGH PERFORMANCE ESTIMATION OF GEBOES SCORE IN ULCERATIVE COLITIS USING MULTI-INSTANCE LEARNING AND FOUNDATIONAL MODELS

GASTROENTEROLOGY

Publication précédente

Differential and Combinatorial Mechanism of Action of Golimumab and Guselkumab in Ulcerative Colitis Induction Therapy: IL-23 Blockade Drives Restoration of Normal Epithelium and Mucosal Healing

GASTROENTEROLOGY

Publication suivante